Release Date: 31/12/12 13:27 Summary: Appendix 3X Initial Director's Interest - G Wilson Price Sensitive: No Download Document 74.66KB Download
MSB Mesoblast resubmits US FDA application for approval of Ryoncil in children with graft vs host disease; shares dip -4%